Clinical Trials Directory

Trials / Unknown

UnknownNCT00488176

Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis

Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation Measured by Exhaled Nitric Oxide Concentration in Children With Seasonal Allergic Rhinitis

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
Medical University of Lodz · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.

Detailed description

During the pollen season children with seasonal allergic rhinitis without concomitant asthma are at risk of having allergic inflammation in the lower respiratory tract. About 60% of children with seasonal allergic rhinitis present bronchial hyperresponsiveness and signs and symptoms of asthma. The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.

Conditions

Interventions

TypeNameDescription
DRUGmontelukastmontelukast sodium
DRUGcetirizinecetirizine
DRUGmontelukast and cetirizinemontelukast and cetirizine
DRUGplaceboplacebo

Timeline

Start date
2007-04-01
Primary completion
2013-11-01
Completion
2013-12-01
First posted
2007-06-20
Last updated
2013-02-07

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT00488176. Inclusion in this directory is not an endorsement.